OpenLB
Open Library of Bioscience
Advanced Search
Frontiers in oncology
2022;12 905868.

A bibliometric and visualization-based analysis of temozolomide research hotspots and frontier evolution.

Peng Song, Hui Li, Kuo Xu, Zi-Wei Li, Xia Ren, Xian-Jun Fu
Author Information
  1. Peng Song: College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
  2. Hui Li: Traditional Chinese Medicine Research Center, Qingdao Academy Shandong University of Traditional Chinese Medicine, Qingdao, China.
  3. Kuo Xu: Traditional Chinese Medicine Research Center, Qingdao Academy Shandong University of Traditional Chinese Medicine, Qingdao, China.
  4. Zi-Wei Li: Traditional Chinese Medicine Research Center, Qingdao Academy Shandong University of Traditional Chinese Medicine, Qingdao, China.
  5. Xia Ren: Traditional Chinese Medicine Research Center, Qingdao Academy Shandong University of Traditional Chinese Medicine, Qingdao, China.
  6. Xian-Jun Fu: College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
PMID: 36457514 DOI: 10.3389/fonc.2022.905868

Abstract

The literature related to TMZ research in the Web of Science (WOS) database was analyzed using bibliometrics and visualization by Citespace and VOSviewer.The publication status (number of publications, institutions, and frequency of citations), collaborations, and research focus was analyzed to clarify the current situation of TMZ research. And the recent research on TMZ provides a detailed summary. Based on objective data analysis, this study provides a complete analysis portraying the progression of historical milestones in TMZ development and future research directions from various TMZ research domains.

Keywords

bibliometrics development process glioblastoma temozolomide web of science

References

  1. Lancet Oncol. 2008 May;9(5):453-61 [PMID: 18452856]
  2. Ann Neurol. 2011 Jul;70(1):9-21 [PMID: 21786296]
  3. Lancet Oncol. 2009 May;10(5):459-66 [PMID: 19269895]
  4. JAMA Oncol. 2021 May 1;7(5):675-676 [PMID: 33475680]
  5. Cancer Res. 1987 Nov 15;47(22):5846-52 [PMID: 3664486]
  6. Nature. 2008 Oct 23;455(7216):1061-8 [PMID: 18772890]
  7. Clin Cancer Res. 2004 Aug 1;10(15):4933-8 [PMID: 15297393]
  8. Oncologist. 2009 Nov;14(11):1131-8 [PMID: 19897538]
  9. J Clin Oncol. 2007 Oct 20;25(30):4722-9 [PMID: 17947719]
  10. Br J Cancer. 1999 Nov;81(6):1022-30 [PMID: 10576660]
  11. Presse Med. 2018 Nov - Dec;47(11-12 Pt 2):e187-e200 [PMID: 30449638]
  12. Brain. 2015 Dec;138(Pt 12):3654-72 [PMID: 26450587]
  13. J Clin Oncol. 2018 Jun 10;36(17):1702-1709 [PMID: 29683790]
  14. Neuro Oncol. 2013 Jun;15(6):735-46 [PMID: 23479134]
  15. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6767-71 [PMID: 16203762]
  16. Nat Rev Dis Primers. 2015 Jul 16;1:15017 [PMID: 27188790]
  17. J Clin Oncol. 2021 Sep 20;39(27):2979-2990 [PMID: 34343032]
  18. Lancet Oncol. 2019 Oct;20(10):1444-1453 [PMID: 31488360]
  19. Med Oncol. 2020 Apr 24;37(6):51 [PMID: 32333196]
  20. JAMA. 2006 Jan 4;295(1):90-3 [PMID: 16391221]
  21. Oncotarget. 2014 Jan 30;5(2):363-74 [PMID: 24495907]
  22. CA Cancer J Clin. 2018 Nov;68(6):471-487 [PMID: 30295930]
  23. Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17268-72 [PMID: 18978030]
  24. Lancet Oncol. 2012 Sep;13(9):916-26 [PMID: 22877848]
  25. N Engl J Med. 2005 Mar 10;352(10):997-1003 [PMID: 15758010]
  26. Autophagy. 2014 Aug;10(8):1369-79 [PMID: 24991839]
  27. Scientometrics. 2015;105(3):1809-1831 [PMID: 26594073]
  28. J Clin Oncol. 2011 Jan 10;29(2):142-8 [PMID: 21135282]
  29. Lancet Oncol. 2017 Jul;18(7):946-957 [PMID: 28549783]
  30. Neuro Oncol. 2016 Oct;18(10):1338-49 [PMID: 27664860]
  31. Biochem Biophys Res Commun. 2015 Aug 7;463(4):638-43 [PMID: 26043698]
  32. J Med Chem. 1995 Apr 28;38(9):1493-504 [PMID: 7739008]
  33. J Clin Oncol. 2018 Apr 1;36(10):951-958 [PMID: 29412784]
  34. Lancet Oncol. 2012 Jul;13(7):707-15 [PMID: 22578793]
  35. Lancet Oncol. 2015 Aug;16(8):908-18 [PMID: 26115796]
  36. PLoS One. 2019 Oct 31;14(10):e0223994 [PMID: 31671124]
  37. J Clin Oncol. 2000 Jan;18(1):158-66 [PMID: 10623706]
  38. J Clin Oncol. 2020 Jul 1;38(19):2160-2169 [PMID: 32343642]
  39. N Engl J Med. 2014 Feb 20;370(8):699-708 [PMID: 24552317]
  40. Front Oncol. 2020 Nov 16;10:566599 [PMID: 33312949]
  41. JAMA. 2015 Dec 15;314(23):2535-43 [PMID: 26670971]
  42. Oncol Rep. 2017 Nov;38(5):2941-2950 [PMID: 29048680]
  43. Proc Natl Acad Sci U S A. 2004 Apr 6;101 Suppl 1:5303-10 [PMID: 14724295]
  44. Lancet Oncol. 2021 Jun;22(6):813-823 [PMID: 34000245]
  45. N Engl J Med. 2017 Mar 16;376(11):1027-1037 [PMID: 28296618]
  46. Mol Cancer. 2020 Feb 10;19(1):28 [PMID: 32039732]
  47. Mol Cancer. 2006 Dec 02;5:67 [PMID: 17140455]
  48. JAMA. 2017 Dec 19;318(23):2306-2316 [PMID: 29260225]
  49. Lancet Oncol. 2014 Sep;15(10):1100-8 [PMID: 25163906]
  50. Lancet Oncol. 2017 Oct;18(10):1373-1385 [PMID: 28844499]
  51. J Clin Oncol. 2009 Mar 10;27(8):1268-74 [PMID: 19204207]
  52. Clin Cancer Res. 1999 Feb;5(2):309-17 [PMID: 10037179]
  53. J Clin Oncol. 2008 Sep 1;26(25):4189-99 [PMID: 18757334]
  54. J Clin Oncol. 2008 May 1;26(13):2192-7 [PMID: 18445844]
  55. Curr Neurol Neurosci Rep. 2005 May;5(3):198-206 [PMID: 15865885]
  56. N Engl J Med. 2005 Mar 10;352(10):987-96 [PMID: 15758009]
  57. N Engl J Med. 2014 Feb 20;370(8):709-22 [PMID: 24552318]
Journal Article Review
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0researchTMZanalysisanalyzedbibliometricsprovidesdevelopmenttemozolomideliteraturerelatedWebScienceWOSdatabaseusingvisualizationCitespaceVOSviewerThepublicationstatusnumberpublicationsinstitutionsfrequencycitationscollaborationsfocusclarifycurrentsituationrecentdetailedsummaryBasedobjectivedatastudycompleteportrayingprogressionhistoricalmilestonesfuturedirectionsvariousdomainsbibliometricvisualization-basedhotspotsfrontierevolutionprocessglioblastomawebscience

Similar Articles

Cited By